ZA200903598B - Lipase variants for pharmaceutical use - Google Patents

Lipase variants for pharmaceutical use

Info

Publication number
ZA200903598B
ZA200903598B ZA200903598A ZA200903598A ZA200903598B ZA 200903598 B ZA200903598 B ZA 200903598B ZA 200903598 A ZA200903598 A ZA 200903598A ZA 200903598 A ZA200903598 A ZA 200903598A ZA 200903598 B ZA200903598 B ZA 200903598B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical use
lipase variants
lipase
variants
pharmaceutical
Prior art date
Application number
ZA200903598A
Other languages
English (en)
Inventor
Allan Svendsen
Michael Skjoet
Debbie Yaver
Lars Lehmann Hylling Christensen
Signe Eskildsen Iarsen
Nina Lundin
Michael Lamsa
Peter Colin Gregory
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Publication of ZA200903598B publication Critical patent/ZA200903598B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA200903598A 2006-12-21 2009-05-25 Lipase variants for pharmaceutical use ZA200903598B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87119606P 2006-12-21 2006-12-21

Publications (1)

Publication Number Publication Date
ZA200903598B true ZA200903598B (en) 2010-04-28

Family

ID=38043020

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903598A ZA200903598B (en) 2006-12-21 2009-05-25 Lipase variants for pharmaceutical use

Country Status (16)

Country Link
US (3) US8273348B2 (cg-RX-API-DMAC7.html)
EP (6) EP2455460A3 (cg-RX-API-DMAC7.html)
JP (1) JP5406040B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090101930A (cg-RX-API-DMAC7.html)
CN (2) CN101743308B (cg-RX-API-DMAC7.html)
AR (1) AR064494A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007337150A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0721103A2 (cg-RX-API-DMAC7.html)
CA (3) CA2670643C (cg-RX-API-DMAC7.html)
IL (1) IL198893A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009006597A (cg-RX-API-DMAC7.html)
NO (1) NO20092729L (cg-RX-API-DMAC7.html)
RU (1) RU2009128067A (cg-RX-API-DMAC7.html)
TW (1) TW200829698A (cg-RX-API-DMAC7.html)
WO (1) WO2008079685A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200903598B (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2381813C2 (ru) 2004-03-22 2010-02-20 Зольвай Фармасьютиклз Гмбх Пероральные фармацевтические композиции на основе продуктов, содержащих липазы, прежде всего панкреатин, и пав
CA2616943C (en) 2005-07-29 2016-04-12 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2455460A3 (en) * 2006-12-21 2012-12-26 Novozymes A/S Lipase variants for pharmaceutical use
EP2250258B1 (en) * 2008-02-29 2017-01-04 Novozymes A/S Lipolytic enzyme variant with improved stability and polynucleotides encoding same
JP2011513539A (ja) * 2008-02-29 2011-04-28 ザ プロクター アンド ギャンブル カンパニー リパーゼを含む洗剤組成物
DK2254996T3 (da) 2008-02-29 2013-10-07 Dsm Ip Assets Bv Lipaser med høj specificitet for kortkædede fedtsyrer og anvendelser deraf
WO2011072117A1 (en) 2009-12-09 2011-06-16 The Procter & Gamble Company Fabric and home care products
CN109022518A (zh) 2011-07-22 2018-12-18 诺维信北美公司 用于预处理纤维素材料和改进其水解的方法
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
CN110777016A (zh) * 2011-12-29 2020-02-11 诺维信公司 具有脂肪酶变体的洗涤剂组合物
CN108148823B (zh) * 2012-02-03 2023-03-14 诺维信公司 脂肪酶变体以及编码它们的多核苷酸
EP2834353B1 (en) * 2012-04-02 2017-07-19 Novozymes A/S Lipase variants and polynucleotides encoding same
EP2906691B1 (en) * 2012-10-12 2021-01-27 Danisco US Inc. Compositions and methods comprising a lipolytic enzyme variant
MX392247B (es) 2013-05-14 2025-03-24 Novozymes As Composiciones detergentes.
EP3022299B1 (en) * 2013-07-19 2020-03-18 Danisco US Inc. Compositions and methods comprising a lipolytic enzyme variant
CN107075489A (zh) * 2014-11-20 2017-08-18 诺维信公司 脂环酸芽孢杆菌变体以及编码它们的多核苷酸
EP4067485A3 (en) * 2014-12-05 2023-01-04 Novozymes A/S Lipase variants and polynucleotides encoding same
EP3230442B1 (en) * 2014-12-09 2019-05-22 Novozymes A/S Lipase variants and polynucleotides encoding same
US20180355404A1 (en) 2015-04-07 2018-12-13 Novozymes A/S Methods for selecting enzymes having lipase activity
EP3929285A3 (en) * 2015-07-01 2022-05-25 Novozymes A/S Methods of reducing odor
WO2017005640A1 (en) * 2015-07-03 2017-01-12 Novozymes A/S Detergent compositions with improved stability in the presence of sulfites
US11326152B2 (en) * 2016-07-18 2022-05-10 Novozymes A/S Lipase variants, polynucleotides encoding same and the use thereof
CN110462037A (zh) * 2017-01-30 2019-11-15 学校法人日本医科大学 腺相关病毒(aav)衣壳蛋白的突变体
US11286443B2 (en) * 2017-09-27 2022-03-29 The Procter & Gamble Company Detergent compositions comprising lipases
CA3073362A1 (en) 2017-09-27 2019-04-04 Novozymes A/S Lipase variants and microcapsule compositions comprising such lipase variants
CN111801416A (zh) * 2018-02-08 2020-10-20 诺维信公司 脂肪酶变体及其组合物
US12269847B2 (en) * 2018-08-16 2025-04-08 Donaldson Company, Inc. Genetically encoded polypeptide for affinity capture and purification of biologics
CN111334369B (zh) * 2020-03-11 2022-10-21 陕西科技大学 一种酶法制备卵磷脂型pufa的方法
EP4172325A1 (en) * 2020-06-24 2023-05-03 Cilian AG New lipase enzyme
US20240035005A1 (en) * 2020-10-29 2024-02-01 Novozymes A/S Lipase variants and compositions comprising such lipase variants
CN113846074B (zh) * 2021-10-20 2022-10-21 南京林业大学 一种疏棉状嗜热丝孢菌脂肪酶突变体g91c及其应用
US20250311734A1 (en) 2022-05-14 2025-10-09 Novozymes A/S Compositions and Methods for Preventing, Treating, Suppressing and/or Eliminatting Phytopathogenic Infestations and Infections
CN119522274A (zh) * 2022-06-24 2025-02-25 诺维信公司 脂肪酶变体和包含这样的脂肪酶变体的组合物

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173590D0 (da) 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
AU657278B2 (en) 1990-09-13 1995-03-09 Novo Nordisk A/S Lipase variants
DK46693D0 (cg-RX-API-DMAC7.html) * 1993-04-23 1993-04-23 Novo Nordisk As
US5869438A (en) 1990-09-13 1999-02-09 Novo Nordisk A/S Lipase variants
WO1992010755A1 (en) 1990-12-05 1992-06-25 Novo Nordisk A/S Proteins with changed epitopes and methods for the production thereof
EP0585285B1 (en) 1991-05-01 1998-08-12 Novo Nordisk A/S Stabilized enzymes
DK39693D0 (da) 1993-04-02 1993-04-02 Novo Nordisk As Enzym
BR9407752A (pt) 1993-10-04 1997-03-04 Novo Nordisk As Preparaçao de enzima aditivo detergente composiçao detergente processo para o tratamento de fibras lignocelulósicas
AU1806795A (en) * 1994-02-22 1995-09-04 Novo Nordisk A/S A method of preparing a variant of a lipolytic enzyme
EP0793726A1 (en) 1994-11-24 1997-09-10 Novo Nordisk A/S A process for producing polypeptides with reduced allergenicity
FI972443L (fi) 1994-12-07 1997-06-09 Novo Nordisk As Polypeptidi, jonka allergeenisuus on vähentynyt
CA2209617C (en) 1995-01-26 2002-05-28 Novo Nordisk A/S Animal feed additives comprising xylanase
US6495357B1 (en) * 1995-07-14 2002-12-17 Novozyme A/S Lipolytic enzymes
ATE282087T1 (de) 1995-07-14 2004-11-15 Novozymes As Modifiziertes enzym mit lipolytischer aktivität
ATE267248T1 (de) 1995-08-11 2004-06-15 Novozymes As Neuartige lipolytische enzyme
EP0954572A1 (en) 1997-01-10 1999-11-10 Novo Nordisk A/S Enzyme coupled with polymeric molecules for skin care
AU740207B2 (en) 1997-02-06 2001-11-01 Novozymes A/S Polypeptide-polymer conjugates having added and/or removed attachment groups
DK1002064T3 (da) 1997-06-25 2008-02-04 Novozymes As Modificeret polypeptid
ATE328070T1 (de) * 1998-02-17 2006-06-15 Novozymes As Lipasevariante
AU3247699A (en) 1998-02-17 1999-09-06 Novo Nordisk A/S Lipase variant
JP2002527059A (ja) 1998-10-13 2002-08-27 ノボザイムス アクティーゼルスカブ 低められた免疫応答を有する修飾されたポリペプチド
CA2348938A1 (en) 1998-10-30 2000-05-11 Novozymes A/S Low allergenic protein variants
ATE365210T1 (de) * 1998-10-30 2007-07-15 Novozymes As Glykosylierte proteine mit reduzierter allergenität
US7312062B2 (en) * 1998-11-27 2007-12-25 Novozymes A/S Lipolytic enzyme variants
WO2000032758A1 (en) 1998-11-27 2000-06-08 Novozymes A/S Lipolytic enzyme variants
ES2194720T3 (es) 1999-03-17 2003-12-01 Solvay Pharm Gmbh Enzimas para el tratamiento de diabetes mellitus tipo i.
MXPA01009700A (es) * 1999-03-31 2002-05-14 Novo Nordisk As Variante de lipasa.
DK1428874T3 (en) * 1999-03-31 2014-03-10 Novozymes As lipase variant
WO2001058275A2 (en) 2000-02-08 2001-08-16 F Hoffmann-La Roche Ag Use of acid-stable subtilisin proteases in animal feed
EP2258852A1 (en) * 2000-04-28 2010-12-08 Novozymes A/S Lipolytic enzyme variant
ES2323947T3 (es) * 2001-01-10 2009-07-28 Novozymes A/S Variante de enzima lipolitica.
AR032392A1 (es) 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
EP1360278B1 (en) 2001-02-07 2009-09-23 Novozymes A/S Lipase variants
AU2003203139B2 (en) * 2002-01-16 2007-11-08 Novozymes A/S Lipolytic enzyme variants and method for their production
AU2004208860A1 (en) 2003-02-06 2004-08-19 Novozymes A/S Human heavy chain antibody expression in filamentous fungi
CA2523400C (en) * 2003-05-09 2015-03-17 Novozymes A/S Variant lipolytic enzymes
WO2004111224A1 (en) 2003-06-19 2004-12-23 Novozymes A/S Improved proteases and methods for producing them
US20060251763A1 (en) 2003-06-19 2006-11-09 Patkar Shamkant A Phospholipase variants
AR047440A1 (es) 2004-01-21 2006-01-18 Novozymes As Produccion de un anticuerpo monoclonal en un hongo heterocarion o una celula huesped fungal
RU2381813C2 (ru) 2004-03-22 2010-02-20 Зольвай Фармасьютиклз Гмбх Пероральные фармацевтические композиции на основе продуктов, содержащих липазы, прежде всего панкреатин, и пав
DE602005022471D1 (de) 2004-10-14 2010-09-02 Altus Pharmaceuticals Inc Zusammensetzungen enthaltend lipase, protease und amylase zur behandlung von pankreasinsuffizienz
US20080138856A1 (en) 2005-02-10 2008-06-12 Novozymes A/S Enzymatic Enantioselective Ester or Amide Hydrolysis or Synthesis
MX2007015472A (es) * 2005-06-24 2008-04-17 Novozymes As Lipasas para uso farmaceutico.
CA2612811A1 (en) 2005-06-24 2006-12-28 Novozymes A/S Amylases for pharmaceutical use
AU2006261443A1 (en) 2005-06-24 2006-12-28 Novozymes A/S Proteases for pharmaceutical use
WO2007080197A2 (en) * 2006-01-16 2007-07-19 Novozymes A/S Immobilised enzymes
AR059154A1 (es) * 2006-01-23 2008-03-12 Procter & Gamble Una composicion que comprende una lipasa y un catalizador de blanqueador
BRPI0707202A2 (pt) * 2006-01-23 2011-04-26 Novozymes Inc variante, seqüência de dna, vetor de expresseão, célula hospedeira transformada, e, método de produzir uma variante de lìpase
EP2455460A3 (en) * 2006-12-21 2012-12-26 Novozymes A/S Lipase variants for pharmaceutical use

Also Published As

Publication number Publication date
US20120308543A1 (en) 2012-12-06
EP2455459A2 (en) 2012-05-23
AU2007337150A1 (en) 2008-07-03
CN101743308B (zh) 2015-09-16
EP2455462A2 (en) 2012-05-23
NO20092729L (no) 2009-09-18
EP2261328A1 (en) 2010-12-15
CA3081308A1 (en) 2008-07-03
JP5406040B2 (ja) 2014-02-05
US20100034797A1 (en) 2010-02-11
CN105112386A (zh) 2015-12-02
CA2670643A1 (en) 2008-07-03
EP2455462B1 (en) 2016-03-16
EP2455459A3 (en) 2013-04-24
CA2961041A1 (en) 2008-07-03
CA2670643C (en) 2017-04-25
EP2455459B1 (en) 2016-03-16
CN101743308A (zh) 2010-06-16
EP2455460A2 (en) 2012-05-23
KR20090101930A (ko) 2009-09-29
EP2455461A2 (en) 2012-05-23
AR064494A1 (es) 2009-04-08
US9029115B2 (en) 2015-05-12
EP2455461A3 (en) 2013-05-29
EP2455462A3 (en) 2013-05-29
EP2455461B1 (en) 2016-03-16
IL198893A0 (en) 2010-02-17
RU2009128067A (ru) 2011-01-27
EP2099907A2 (en) 2009-09-16
EP2261328B1 (en) 2013-11-20
BRPI0721103A2 (pt) 2014-03-04
WO2008079685A2 (en) 2008-07-03
WO2008079685A3 (en) 2008-11-06
TW200829698A (en) 2008-07-16
JP2010512795A (ja) 2010-04-30
CA2961041C (en) 2020-07-14
CA3081308C (en) 2024-02-20
US9539311B2 (en) 2017-01-10
MX2009006597A (es) 2009-07-02
US20150209414A1 (en) 2015-07-30
EP2455460A3 (en) 2012-12-26
US8273348B2 (en) 2012-09-25

Similar Documents

Publication Publication Date Title
ZA200903598B (en) Lipase variants for pharmaceutical use
ZA200710643B (en) Lipases for pharmaceutical use
ZA200809546B (en) Pharmaceutical compounds
PL2399579T3 (pl) Farmaceutyczne postacie dawkowania
GB0608820D0 (en) Pharmaceutical compounds
ZA200806318B (en) Drug combinations
IL205952A0 (en) Protease variants for pharmaceutical use
IL197883A0 (en) Combination drug
GB0625783D0 (en) Medicament
GB0608176D0 (en) Pharmaceutical Compounds
GB0608184D0 (en) Pharmaceutical compounds
GB0615064D0 (en) Medicament
GB0608175D0 (en) Pharmaceutical Compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0615814D0 (en) Medicament
ZA200708369B (en) Medicament
GB0614457D0 (en) Pharmaceutical Combinations
GB0625433D0 (en) Pharmaceutical combinations
GB0618135D0 (en) Novel pharmaceutical
GB0622332D0 (en) Drug
ZA200902756B (en) Combination drug
GB0615299D0 (en) Pharmaceutical compounds
GB0613520D0 (en) Pharmaceutical compounds